125 related articles for article (PubMed ID: 2846525)
21. Different induction of two plasminogen activator inhibitor 1 mRNA species by phorbol ester in human hepatoma cells.
Bosma PJ; Kooistra T
J Biol Chem; 1991 Sep; 266(27):17845-9. PubMed ID: 1655729
[TBL] [Abstract][Full Text] [Related]
22. Modulation of mRNA levels for urinary- and tissue-type plasminogen activator and plasminogen activator inhibitors 1 and 2 in human fibroblasts by interleukin 1.
Michel JB; Quertermous T
J Immunol; 1989 Aug; 143(3):890-5. PubMed ID: 2501387
[TBL] [Abstract][Full Text] [Related]
23. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
Gyetko MR; Webb AC; Sitrin RG
J Immunol; 1988 Oct; 141(8):2693-8. PubMed ID: 3139763
[TBL] [Abstract][Full Text] [Related]
24. Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.
Fujii S; Lucore CL; Hopkins WE; Billadello JJ; Sobel BE
Thromb Haemost; 1990 Nov; 64(3):412-9. PubMed ID: 2128971
[TBL] [Abstract][Full Text] [Related]
25. Cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor messenger RNAs in rat hepatoma cells.
Heaton JH; Gelehrter TD
Mol Endocrinol; 1990 Jan; 4(1):171-8. PubMed ID: 2157975
[TBL] [Abstract][Full Text] [Related]
26. Expression of tissue-type plasminogen activator and its inhibitor couples with development of capillary network by human microvascular endothelial cells on Matrigel.
Ito K; Ryuto M; Ushiro S; Ono M; Sugenoya A; Kuraoka A; Shibata Y; Kuwano M
J Cell Physiol; 1995 Feb; 162(2):213-24. PubMed ID: 7822431
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of vitronectin expression in human HepG2 hepatoma cells by transforming growth factor-beta 1.
Koli K; Lohi J; Hautanen A; Keski-Oja J
Eur J Biochem; 1991 Jul; 199(2):337-45. PubMed ID: 1712727
[TBL] [Abstract][Full Text] [Related]
28. Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.
Quax PH; van den Hoogen CM; Verheijen JH; Padro T; Zeheb R; Gelehrter TD; van Berkel TJ; Kuiper J; Emeis JJ
J Biol Chem; 1990 Sep; 265(26):15560-3. PubMed ID: 2118527
[TBL] [Abstract][Full Text] [Related]
29. Heparin-binding epidermal growth factor-like growth factor: p91 activation induction of plasminogen activator/inhibitor, and tubular morphogenesis in human microvascular endothelial cells.
Ushiro S; Ono M; Izumi H; Kohno K; Taniguchi N; Higashiyama S; Kuwano M
Jpn J Cancer Res; 1996 Jan; 87(1):68-77. PubMed ID: 8609052
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation of the plasminogen activator inhibitor-1 (PAI-1) gene expression by growth factors and progesterone in human endometrial stromal cells.
Sandberg T; Eriksson P; Gustavsson B; Casslén B
Mol Hum Reprod; 1997 Sep; 3(9):781-7. PubMed ID: 9358004
[TBL] [Abstract][Full Text] [Related]
31. Glucocorticoid and cyclic nucleotide regulation of plasminogen activator and plasminogen activator-inhibitor gene expression in primary cultures of rat hepatocytes.
Heaton JH; Nebes VL; O'Dell LG; Morris SM; Gelehrter TD
Mol Endocrinol; 1989 Jan; 3(1):185-92. PubMed ID: 2536889
[TBL] [Abstract][Full Text] [Related]
32. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.
Konkle BA; Ginsburg D
J Clin Invest; 1988 Aug; 82(2):579-85. PubMed ID: 3136192
[TBL] [Abstract][Full Text] [Related]
33. Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression. Interaction with cAMP and protein kinase C-mediated pathways.
Konkle BA; Kollros PR; Kelly MD
J Biol Chem; 1990 Dec; 265(35):21867-73. PubMed ID: 1701436
[TBL] [Abstract][Full Text] [Related]
34. Phorbol ester induces the biosynthesis of glycosylated and nonglycosylated plasminogen activator inhibitor 2 in high excess over urokinase-type plasminogen activator in human U-937 lymphoma cells.
Genton C; Kruithof EK; Schleuning WD
J Cell Biol; 1987 Mar; 104(3):705-12. PubMed ID: 3102504
[TBL] [Abstract][Full Text] [Related]
35. Control of plasminogen-activator inhibitor type 2 gene expression in the differentiation of monocytic cells.
Antalis TM; Dickinson JL
Eur J Biochem; 1992 Apr; 205(1):203-9. PubMed ID: 1555580
[TBL] [Abstract][Full Text] [Related]
36. Plasminogen activator inhibitor type-1 protein, mRNA and gene transcription are increased by phorbol esters in human rhabdomyosarcoma cells.
Mayer M; Lund LR; Riccio A; Skouv J; Nielsen LS; Stacey SN; Danø K; Andreasen PA
J Biol Chem; 1988 Oct; 263(30):15688-93. PubMed ID: 3262618
[TBL] [Abstract][Full Text] [Related]
37. Synergistic and multidimensional regulation of plasminogen activator inhibitor type 1 expression by transforming growth factor type β and epidermal growth factor.
Song X; Thalacker FW; Nilsen-Hamilton M
J Biol Chem; 2012 Apr; 287(15):12520-8. PubMed ID: 22334677
[TBL] [Abstract][Full Text] [Related]
38. Differential regulation of cell proliferation and protease secretion by epidermal growth factor and amphiregulin in tumoral versus normal breast epithelial cells.
Silvy M; Giusti C; Martin PM; Berthois Y
Br J Cancer; 2001 Apr; 84(7):936-45. PubMed ID: 11286474
[TBL] [Abstract][Full Text] [Related]
39. Regulation of plasminogen activator inhibitor-1 mRNA in human endothelial cells.
van den Berg EA; Sprengers ED; Jaye M; Burgess W; Maciag T; van Hinsbergh VW
Thromb Haemost; 1988 Aug; 60(1):63-7. PubMed ID: 2460966
[TBL] [Abstract][Full Text] [Related]
40. Post-transcriptional regulation of expression of plasminogen activator inhibitor type 1 mRNA by insulin and insulin-like growth factor 1.
Fattal PG; Schneider DJ; Sobel BE; Billadello JJ
J Biol Chem; 1992 Jun; 267(18):12412-5. PubMed ID: 1618746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
